Ranolazine and its anti-ischemic effects: Revisiting an old mechanistic paradigm anew?

Journal of the American College of Cardiology

Volumn 56, Issue 12, 2010, Pages 943-945

  Boden, William E ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DILTIAZEM; PLACEBO; RANOLAZINE; VERAPAMIL;

CLINICAL TRIAL; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG MECHANISM; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE OXYGEN CONSUMPTION; HEART RATE; HUMAN; MONOTHERAPY; NOTE; PRIORITY JOURNAL; ST SEGMENT DEPRESSION; STABLE ANGINA PECTORIS; SYSTOLIC BLOOD PRESSURE;

EID: 77956541149     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.07.010     Document Type: Editorial

References (32)

1. R. Tennant, and C.J. Wiggers The effects of coronary occlusion on myocardial contraction Am J Physiol 112 1935 351 361
2. R.W. Nesto, and G.J. Kowalchuk The ischemic cascade: temporal sequence of hemodynamic, electrocardiographic, and symptomatic expressions of ischemia Am J Cardiol 59 1987 23C 30C
3. R.D. Foreman Mechanisms of cardiac pain Ann Rev Physiol 61 1999 143 150
4. S. Epstein, D.R. Redwood, and R.E. Goldstein Angina pectoris: pathophysiology, evaluation, and treatment Ann Intern Med 75 1971 263 296
5. R.J. Gibbons, J. Abrams, and K. Chatterjee ACC/AHA 2002 guideline update for the management of patients with chronic stable anginasummary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina) J Am Coll Cardiol 41 2003 159 168 (Pubitemid 36044419)
6. G. Jackson, J. Schwartz, R.E. Kates, M. Winchester, and D.C. Harrison Atenolol: once-daily cardioselective beta blockade for angina pectoris Circulation 61 1980 555 560
7. R. Weiss, D. Ferry, E. Pickering Carvedilol-Angina Study Group Effectiveness of three different doses of carvedilol for exertional angina Am J Cardiol 82 1998 927 931
8. J.C. Kaski, L. Rodriguez-Plaza, J. Brown, and A. Maseri Efficacy of carvedilol (BM 14, 190), a new beta-blocking drug with vasodilating properties, in exercise-induced ischemia Am J Cardiol 56 1985 35 40
9. B. Furberg, A. Dahlqvist, A. Raak, and U. Wrege Comparison of the new beta-adrenoceptor antagonist, nadolol, and propranolol in the treatment of angina pectoris Curr Med Res Opin 5 1978 388 393
10. G. Jackson, J.D. Harry, C. Robinson, D. Kitson, and D.E. Jewitt Comparison of atenolol with propranolol in the treatment of angina pectoris with special reference to once daily administration of atenolol Br Heart J 40 1978 998 1004
11. J. Waysbort, N. Meshulam, and D. Brunner Isosorbide-5-mononitrate and atenolol in the treatment of stable exertional angina Cardiology 79 Suppl 2 1991 19 26
12. H.P. Krepp Evaluation of the antianginal and anti-ischemic efficacy of slow-release isosorbide-5-mononitrate capsules, bupranolol and their combination, in patients with chronic stable angina pectoris Cardiology 79 Suppl 2 1991 14 18
13. M.H. Alderman, H. Cohen, and R. Roque Effect of long-acting and short-acting calcium antagonists on cardiovascular outcomes in hypertensive patients Lancet 349 1997 594 598
14. D.A. Weiner, and M.D. Klein Verapamil therapy for stable exertional angina pectoris Am J Cardiol 50 1982 1153 1157
15. V.B. Subramanian Calcium channel blockade as primary therapy for stable angina pectoris A double-blind placebo-controlled comparison of verapamil and propranolol Am J Cardiol 50 1982 1158 1163
16. R.A. Chahine Amlodipine Study 160 Group Randomized placebo-controlled trial of amlodipine in vasospastic angina J Am Coll Cardiol 21 1993 1365 1370
17. P.H. Stone, B.R. Chaitman, K. Stocke, J. Sano, A. DeVault, and G.G. Koch The anti-ischemic mechanism of action of ranolazine in stable ischemic heart disease J Am Coll Cardiol 56 2010 934 942
18. B.R. Chaitman, C.J. Pepine, and J.O. Parker Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial JAMA 291 2004 309 316
19. D.A. Morrow, B.M. Scirica, and E. Karwatowska-Prokopczuk Effects of ranolazine on recurrent cardiovascular events in patients with nonST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial JAMA 297 2007 1775 1783
20. S.R. Wilson, B.M. Scirica, and E. Braunwald Efficacy of ranolazine in patients with chronic angina: observations from the randomized, double-blind, placebo-controlled MERLIN-TIMI 36 Trial J Am Coll Cardiol 53 2009 1510 1516
21. L. Belardinelli, J.C. Shryock, and H. Fraser The mechanism of ranolazine action to reduce ischemia-induced diastolic dysfunction Eur Heart J 8 2006 A10 A13
22. A. Zaza, L. Belardinelli, and J.C. Shryock Pathophysiology and pharmacology of the cardiac "late sodium current." Pharmacol Ther 119 2008 326 339
23. B.R. Chaitman Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions Circulation 113 2006 2462 2472
24. D.T. Nash, and S.D. Nash Ranolazine for chronic stable angina Lancet 372 2008 1335 1341
25. J.C. Shryock, and L. Belardinelli Inhibition of late sodium current to reduce electrical and mechanical dysfunction of ischaemic myocardium Br J Pharmacol 153 2008 1128 1132
26. M.P. Chandler, W.C. Stanley, and H. Morita Short-term treatment with ranolazine improves mechanical efficiency in dogs with chronic heart failure Circ Res 91 2002 278 280
27. S.L. Hale, J.A. Leeka, and R.A. Kloner Improved left ventricular function and reduced necrosis after myocardial ischemia/reperfusion in rabbits treated with ranolazine, an inhibitor of the late sodium channel J Pharmacol Exp Ther 318 2006 418 423
28. S.L. Hale, J.C. Shryock, L. Belardinelli, M. Sweeney, and R.A. Kloner Late sodium current inhibition as a new cardioprotective approach J Mol Cell Cardiol 44 2008 954 967
29. M.F. Rousseau, G. Cocco, and T. Boury Novel metabolic modulator ranolazine selectively improves diastolic function in heart failure Circulation 86 Suppl I 1992 I375
30. M.F. Rousseau, G. Cocco, and T. Boury Effects of a novel metabolic modulator, ranolazine on exercise tolerance and left ventricular filling dynamics in patients with angina pectoris Circulation 86 Suppl I 1992 I714
31. W. Hayashida, C. VanEyell, M.F. Rousseau, and H. Pouleur Effects of ranolazine on left ventricular regional diastolic function in patients with ischemic heart disease Cardiovasc Drug Ther 8 1994 741 747
32. R. Venkataraman, L. Belardinelli, B. Blackburn, J. Heo, and A.E. Iskandrian A study of the effects of ranolazine using automated quantitative analysis of serial myocardial perfusion images J Am Coll Cardiol Img 2 2009 1301 1309